Cargando…
CD27 expression on Treg cells limits immune responses against tumors
ABSTRACT: Regulatory T cells (Tregs) suppress immune responses and thus contribute to immune homeostasis. On the downside, Tregs also limit immune responses against tumors promoting the progression of cancer. Among the many mechanisms implied in Treg-mediated suppression, the inhibition of dendritic...
Autores principales: | Muth, Sabine, Klaric, Annekatrin, Radsak, Markus, Schild, Hansjörg, Probst, Hans Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843905/ https://www.ncbi.nlm.nih.gov/pubmed/34423375 http://dx.doi.org/10.1007/s00109-021-02116-9 |
Ejemplares similares
-
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection
por: Hartmann, Ann-Kathrin, et al.
Publicado: (2023) -
Tumor-infiltrating CCR2(+) inflammatory monocytes counteract specific immunotherapy
por: Bartneck, Joschka, et al.
Publicado: (2023) -
Regulatory T Cells and IL-10 Independently Counterregulate Cytotoxic T Lymphocyte Responses Induced by Transcutaneous Immunization
por: Stein, Pamela, et al.
Publicado: (2011) -
Efficacy of Imiquimod-Based Transcutaneous Immunization Using a Nano-Dispersed Emulsion Gel Formulation
por: Stein, Pamela, et al.
Publicado: (2014) -
Evaluation and Validation of the Detection of soluble Triggering Receptor Expressed on Myeloid Cells 1 by Enzyme-linked immunosorbent Assay
por: Hasibeder, Astrid, et al.
Publicado: (2015)